FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer. - Marmé, F.; Werft, W.; Benner, A.; Burwinkel, B.; Sinn, P.; Sohn, C.; Lichter, P.; Hahn, M.; Schneeweiss, A. (Annals of Oncology, 2010)